From Chai To Pills: India's Sweet Spot In The Diabetes Market

By Krishna Raj K | August, 2024

On my way to Mumbai during a drizzling monsoon, I found myself on an enchanting 20-hour train journey. With little to do and limited network coverage, I turned to my fellow passenger for a conversation—after all, it was better than being glued to my phone.

After the usual small talk, the aroma of chai filled the air. Who could resist a hot cup of tea on a rainy day in an air-conditioned compartment? It was the perfect remedy for the boredom. As the chai wala made his rounds, three out of the eight passengers requested their chai without sugar. This wasn’t surprising, given that I come from the diabetic capital of India.

What did catch me off guard, was the chai wala's pitch the next morning. With a grin, he announced, "Sugarless chai!" and a whole lot of fellow passengers in each cabin peeping their heads out waiting for him. The surprising element wasn't just the demand for sugarless chai but the realization that so many individuals were actively managing their sugar intake, reflecting the widespread impact of diabetes in the region.

So, my usual tendency would be to Google this rather than ask my fellow passengers. After all, no one wants to ruin a good conversation by diving into serious topics. Instead, I observed and made a mental note of their dietary preferences.

As the journey continued, it became obvious that health-conscious choices were more common than I expected. The preference for sugarless chai wasn't just a casual choice, it seemed to be part of a larger trend, likely due to the rise in diabetes. It was interesting to see how people's eating habits were changing, even in a simple setting like a train ride.

Well say bye-bye to my fellow passengers and let’s play the number games.

If you have observed the phrase “I have sugar” is now a common norm and is often used because “1 in 10 Indians suffer from diabetes”. So, every time you offer something sweet to someone sweet, they will go like I have sugar.?

India now accounts for 10.1 crores of diabetic patients as of 2023. The study also states that the number of diabetic patients has increased by 44% in 4 years.

Diabetes Across States

India's party capital, Goa, leads with the highest diabetes rate at 26.4%, proving its beaches aren’t the only thing that are sweet. Puducherry follows at 26.3%, and Kerala is third at 25.5%. In contrast, Uttar Pradesh has the lowest prevalence at 4.8%.

Additionally, 15.3% of the population, or about 136 million people, are pre-diabetic. This means their blood sugar levels are higher than normal but not yet diabetic—essentially a warning sign. Without significant lifestyle changes, many of these individuals are at risk of developing diabetes.

Pre-Diabetes Across States

The prevalence of prediabetes was highest in the central and northern regions of India and lowest in Punjab, Jharkhand, and some parts of the northeastern region.

So there is a huge segment of population heading towards this silent killer and it is obvious that a thriving pharmaceutical industry will naturally follow to cater to the growing demand for diabetes management and treatment solutions.?

"Next time you’re enjoying a family meal, swap the regular white rice for brown rice or millet— your blood sugar levels will stay happier!"

Let's dive into why the diabetes market is placing the pharma industry in a sweet spot.

We all know the pharmaceutical sector in India is witnessing significant growth, but did you know that anti-diabetic drugs are leading the way?

According to the International Journal of Pharmaceutical Science Indian diabetic market is estimated at INR 316 billion in 2023.?

It is expected to grow at a CAGR of 16% from 2024-2032, reaching INR 1201.74 billion by 2032.?

It is evident that the market for diabetes care is huge and continues to expand. The rising prevalence of diabetes in India and the ongoing need for effective treatment options make it a key focus area for pharmaceutical companies and investors.

Key Players in the India Diabetes Care Drugs Market

The diabetes drugs market in India is somewhat competitive, with both major and generic players involved. The insulin and SGLT-2 drug segments are mainly controlled by big companies like Novo Nordisk, Sanofi, AstraZeneca, and Bristol Myers Squibb. On the other hand, the market for oral drugs, such as Sulfonylureas and Meglitinides, has more participation from generic drug manufacturers. Competition is strong, with companies constantly working to develop new medications and offer them at competitive prices. Additionally, these companies are expanding into new markets, particularly in emerging economies where demand outpaces supply.

“Next time you’re admiring the sweeping city view from a high-rise office like Harvey Specter’s, do your health a favor—take the stairs!”

Growth Drivers for Diabetes

By now, you would be convinced that the exiting market of diabetic patients is large enough to keep current market players in the segment thriving.

Going forward, here are a few key factors that will drive the growth of diabetes in the pharmaceutical industry:

So, what's the takeaway from all this? If India's love for chai is any indication, we're sipping our way through a sweet but somewhat risky journey. From sugarless chai in train compartments to a booming pharmaceutical industry, it’s clear that diabetes has become more than just a health issue— it's a market opportunity, a lifestyle change. With 10.1 crore Indians already diagnosed and millions more on the edge, the diabetes market in India is like that stubborn uncle who just won't say no to the extra gulab jamun—growing steadily and showing no signs of stopping.

As we continue to urbanize, age, and adopt tech-savvy solutions, the demand for diabetes care will only rise. So, whether you’re enjoying a sugarless chai or eyeing the latest insulin pumps, just remember: in India, we’re not just managing diabetes—we're capitalizing on it. As diabetes cases skyrocket, the pharma industry is finding a lucrative sweet spot. It's time we replace sugar rushes with health crushes.

Some Good Reads!

1. Analyzing the top 3 factors contributing to Diabetes in India and how to address them
2. Why India is the diabetes capital of the world
3. Market Analysis of Antidiabetic Drugs in India

Thank You for reading! See you Next Month!

?